Terminal differentiation into adipocyte and growth inhibition by PPARγ activation in human A549 lung adenocarcinoma cells

The present study investigated the terminal differentiation capacity into adipocytes and subsequent growth inhibition in A549 cancer cells treated with pioglitazone (PGZ), a PPARγ activator. The rate of cell growth in A549 cells was significantly (P < .05) inhibited in concentrations above 10 μM...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dae-Young, Moon, Sun-Ha, Han, Jang-Ho, Kim, Mi-Jeong, Oh, Seong-Ju, Bharti, Dinesh, Lee, Sung-Ho, Park, Jong-Kuen, Rho, Gyu-Jin, Jeon, Byeong-Gyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781920/
https://www.ncbi.nlm.nih.gov/pubmed/33456717
http://dx.doi.org/10.1080/19768354.2020.1847731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781920/
https://www.ncbi.nlm.nih.gov/pubmed/33456717
http://dx.doi.org/10.1080/19768354.2020.1847731

Ejemplares similares